1 / 7

Cawthron Micro-algae Culture Collection

Cawthron Micro-algae Culture Collection Lesley Rhodes Manager Biosecurity Gp: Mike Taylor Curator: Krystyna Ponikla. Cawthron Micro-algae Culture Collection. Began with personal collections in 1980s FRST funded from 1995; purpose built facility

odette
Télécharger la présentation

Cawthron Micro-algae Culture Collection

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cawthron Micro-algae Culture CollectionLesley RhodesManager Biosecurity Gp: Mike TaylorCurator: Krystyna Ponikla

  2. Cawthron Micro-algae Culture Collection • Began with personal collections in 1980s • FRST funded from 1995; purpose built facility • 1996: FRST recommended registration as NDB • Catalogue of strains in Jan. 2003 lists: • 8 classes of micro-algae; >150 isolates

  3. Underpins harmful algae research This year already 16 requests (67 micro-algae) Last 5 years 65 requests Programmes directly dependent on collection: • Harmful algae bloom technologies - new bioactive compounds - biotoxin standards - DNA probe development - training • Micro-algae for medical products

  4. Valuable compounds produced • Saxitoxin, gonyautoxins • Domoic acid • Brevetoxins • Okadaic acid, diol esters • Yessotoxin • Pectenotoxin • Azaspiracid • Palytoxin, ostreocin • Cooliatoxin • Cyanotoxins • etc……

  5. New compounds – but are they of human concern? • Yessotoxin (polyether) – from collection grew 400 L to retrieve 140 mg YTX (plus >60 analogs)

  6. Key end-users • NZ shellfish industry (biotoxin detection methods / risk assessments for harvesters) • NZ finfish industry (risk assessments) • Research groups – national and international “… according to the number of strains you hold (@150) you would be highly ranked in the Asia-Pacific region, in which there are about 20 collections listing micro-algae.” Ian Jameson, CSIRO, Hobart.

  7. Future developments • Cryopreservation of algal strains to: • preserve toxicity • reduce labour • reduce costs • More trained staff to relieve burden on one curator! • Key issue is insecurity of collection due to contestable funding

More Related